Your browser doesn't support javascript.
loading
Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study.
Fujino, Haruo; Takahashi, Masanori P; Nakamura, Harumasa; Heatwole, Chad R; Takada, Hiroto; Kuru, Satoshi; Ogata, Katsuhisa; Enomoto, Kiyoka; Hayashi, Yuto; Imura, Osamu; Matsumura, Tsuyoshi.
Affiliation
  • Fujino H; United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan.
  • Takahashi MP; Clinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
  • Nakamura H; Department of Clinical Research Support, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
  • Heatwole CR; Department of Neurology, University of Rochester, Rochester, NY, USA.
  • Takada H; Center for Health and Technology, Rochester, NY, USA.
  • Kuru S; Department of Neurology, NHO Aomori National Hospital, Aomori, Japan.
  • Ogata K; Department of Neurology, NHO Suzuka National Hospital, Suzuka, Mie, Japan.
  • Enomoto K; Department of Neurology, NHO Higashisaitama National Hospital, Hasuda, Saitama, Japan.
  • Hayashi Y; United Graduate School of Child Development, Osaka University, Suita, Osaka, Japan.
  • Imura O; Pain Management Clinic, Shiga University of Medical Science Hospital, Otsu, Shiga, Japan.
  • Matsumura T; Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Disabil Rehabil ; : 1-10, 2024 Mar 31.
Article in En | MEDLINE | ID: mdl-38555736
ABSTRACT

PURPOSE:

The Facioscapulohumeral Muscular Dystrophy Health Index (FSHD-HI) is a patient-reported outcome measure developed for patients with FSHD. This study aimed to translate the FSHD-HI into Japanese (FSHD-HI-J), evaluate cultural adaptation, and examine its psychometric properties. MATERIALS AND

METHODS:

We created two forward translations, integrated them into a single Japanese version, and evaluated the back-translated version of the FSHD-HI. After finalizing the translation and cultural adaptation, we conducted a survey of 66 patients with FSHD to examine the reliability and validity of the FSHD-HI-J. For psychometric evaluations, we used Cronbach's alpha to assess internal consistency, the intraclass correlation coefficient (ICC) for test-retest reliability, and assessed validity based on the associations between FSHD-HI-J, clinical variables, and quality of life measures.

RESULTS:

The FSHD-HI-J was found to be clinically relevant, indicating high internal consistency and test-retest reliability (ICC = 0.92 [95% confidence interval 0.86-0.95] for the total score), as well as significant associations with clinical variables (D4Z4 repeats and functional impairment) and other quality of life measures (|rho| = 0.25-0.73).

CONCLUSIONS:

The FSHD-HI-J is a valid and reliable patient-reported outcome measure for Japanese patients with FSHD. This validated, disease-specific patient-reported outcome is essential for future clinical practice and clinical trials.
Facioscapulohumeral muscular dystrophy (FSHD) affects not only a patient's physical abilities but also their social activities, participation, and overall quality of life.The FSHD-Health Index (FSHD-HI) is an instrument developed as a disease-specific patient-reported outcome measure to evaluate the burden experienced by patients.The Japanese version of the FSHD-HI has been established as a reliable and validated measure for Japanese-speaking patients with FSHD.The Japanese version of the FSHD-HI can serve as a useful instrument for evaluating the effectiveness of interventions in future trials.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Disabil Rehabil Journal subject: REABILITACAO Year: 2024 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Disabil Rehabil Journal subject: REABILITACAO Year: 2024 Document type: Article Affiliation country: Japón